TRAILBLAZER-2, a Phase 3 study, has enrolled 1,600 participants. Prescreening with plasma p-tau-181 helped select people with both amyloid and tau pathology. A secondary prevention trial, ...
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis ...
Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results